Profund Advisors LLC Stoke Therapeutics, Inc. Transaction History

Profund Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$5.9 - $11.84 $11,186 - $22,448	-1,896 Reduced 14.72%	10,986 $124,000
Q1 2025 May 08, 2025	SELL	$6.65 - $12.74 $1,768 - $3,388	-266 Reduced 2.02%	12,882 $85,000
Q4 2024 Feb 13, 2025	SELL	$10.8 - $13.92 $35,132 - $45,281	-3,253 Reduced 19.83%	13,148 $145,000
Q3 2024 Nov 13, 2024	BUY	$12.24 - $15.92 $18,457 - $24,007	1,508 Added 10.13%	16,401 $201,000
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $164,269 - $260,925	14,893 New	14,893 $201,000

160

60.2M

563K

101K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.05B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.